1101047

Syntho Pharmaceuticals, Inc. — FEI 3003407422

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 3, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Farmingdale, NY (United States)

Citations

IDCFRDescription
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
176721 CFR 211.137(a)Expiration date lacking
180921 CFR 211.160(a)Following/documenting laboratory controls
189021 CFR 211.165(e)Test methods
194321 CFR 211.180(e)(1)Review of representative number of batches
2129421 CFR 211.110(b)In-process specification, invalid
360321 CFR 211.160(b)Scientifically sound laboratory controls
361321 CFR 211.160(b)(4)Establishment of calibration procedures
361521 CFR 211.160(b)(4)Test devices not meeting specifications
363221 CFR 211.170(b)Annual visual exams of drug products
430321 CFR 211.67(b)Written procedures fail to include
430621 CFR 211.80(a)Written Procedures Not Followed
438921 CFR 211.198(a)Procedures to be written and followed